Implications of RNA pseudouridylation for cancer biology and therapeutics: a narrative review

被引:2
|
作者
Ding, Hanyi [1 ,2 ]
Liu, Na [3 ,5 ]
Wang, Yan [1 ,3 ]
Adam, Sofia Abdulkadir [3 ]
Jin, Jie [1 ,3 ,4 ]
Feng, Weiying [2 ]
Sun, Jie [1 ,3 ,4 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Zhejiang, Peoples R China
[2] Shaoxing Peoples Hosp, Dept Hematol, Shaoxing, Zhejiang, Peoples R China
[3] Key Lab Hematol Malignancies Diag & Treatment, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Prov Clin Res Ctr Hematol Disorders, Hangzhou, Zhejiang, Peoples R China
[5] Weifang Med Univ, Affiliated Hosp, Sch Clin Med, Dept Oncol, Weifang, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Pseudouridine; RNA modification; Pseudouridine synthase; Cancer diagnosis; Cancer treatment; MESSENGER-RNA; URINARY PSEUDOURIDINE; SERUM PSEUDOURIDINE; MODIFIED NUCLEOTIDES; TRANSLATION CONTROL; BIOCHEMICAL MARKER; DKC1; NUCLEOSIDES; DIAGNOSIS; EXPRESSION;
D O I
10.1186/s12967-024-05687-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundPseudouridine (Psi), a C5-glycoside isomer of uridine, stands as one of the most prevalent RNA modifications in all RNA types. Distinguishing from the C-N bond linking uridine to ribose, the link between Psi and ribose is a C-C bond, endowing Psi modified RNA distinct properties and functions in various biological processes. The conversion of uridine to Psi is governed by pseudouridine synthases (PUSs). RNA pseudouridylation is implicated in cancer biology and therapeutics.ObjectivesIn this review, we will summarize the methods for detecting Psi, the process of Psi generation, the impact of Psi modification on RNA metabolism and gene expression, the roles of dysregulated Psi and pseudouridine synthases in cancers, and the underlying mechanism.MethodsWe conducted a comprehensive search of PubMed from its inception through February 2024. The search terms included "pseudouridine"; "pseudouridine synthase"; "PUS"; "dyskerin"; "cancer"; "tumor"; "carcinoma"; "malignancy"; "tumorigenesis"; "biomarker"; "prognosis" and "therapy". We included studies published in peer-reviewed journals that focused on Psi detection, specific mechanisms involving Psi and PUSs, and prognosis in cancer patients with high Psi expression. We excluded studies lacking sufficient methodological details or appropriate controls.Results Psi has been recognized as a significant biomarker in cancer diagnosis and prognosis. Abnormal Psi modifications mediated by various PUSs result in dysregulated RNA metabolism and impaired RNA function, promoting the development of various cancers. Overexpression of PUSs is common in cancer cells and predicts poor prognosis. PUSs inhibition arrests cell proliferation and enhances apoptosis in cancer cells, suggesting PUS-targeting cancer therapy may be a potential strategy in cancer treatment.DiscussionHigh Psi levels in serum, urine, and saliva may suggest cancer, but do not specify the type, requiring additional lab markers and imaging for accurate diagnosis. Standardized detection methods are also crucial for reliable results. PUSs are linked to cancer, but more researches are needed to understand their mechanisms in different cancers. Anticancer treatments targeting PUSs are still under developed.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] RNA in Biology and Therapeutics
    Jeong, Sunjoo
    MOLECULES AND CELLS, 2023, 46 (01) : 1 - 2
  • [2] RNA biology and therapeutics
    Wang, Puyue
    Xue, Yuanchao
    Qi, Yijun
    Chen, Runsheng
    FUNDAMENTAL RESEARCH, 2023, 3 (05): : 655 - 656
  • [3] Nanotechnology in Lung Cancer Therapeutics: A Narrative Review
    Koutu, Vaibhav
    Gupta, Manish
    Das, Saikat
    Rawat, Deepak K.
    Kharade, Vipin
    Pasricha, Rajesh K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [4] RNA therapeutics to control fibrinolysis: review on applications in biology and medicine
    Ferraresso, Francesca
    Leung, Jerry
    Kastrup, Christian J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (08) : 2103 - 2114
  • [5] A promising RNA nanotechnology in clinical therapeutics: a future perspective narrative review
    Tolba, Mahmoud M.
    Jabbar, Abdul
    Afzal, Sadia
    Mahmoud, Mohammed
    Zulfiqar, Farheen
    El-Soudany, Ingy
    Samir, Salma
    Wadan, Al-Hassan Soliman
    Ellakwa, Takwa E.
    Ellakwa, Doha El-Sayed
    FUTURE SCIENCE OA, 2023, 9 (08):
  • [6] Alterations of ribosomal RNA pseudouridylation in human breast cancer
    Barozzi, Chiara
    Zacchini, Federico
    Corradini, Angelo Gianluca
    Morara, Monica
    Serra, Margherita
    De Sanctis, Veronica
    Bertorelli, Roberto
    Dassi, Erik
    Montanaro, Lorenzo
    NAR CANCER, 2023, 5 (02):
  • [7] RNA interference therapeutics for cancer: Challenges and opportunities (Review)
    Bora, Roop Singh
    Gupta, Dikshi
    Mukkur, Trilochan Kanwaljit Singh
    Saini, Kulvinder Singh
    MOLECULAR MEDICINE REPORTS, 2012, 6 (01) : 9 - 15
  • [8] Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics
    Chakedis, Jeffery
    French, Randall
    Babicky, Michele
    Jaquish, Dawn
    Mose, Evangeline
    Cheng, Peter
    Holman, Patrick
    Howard, Haleigh
    Miyamoto, Jaclyn
    Porras, Paula
    Walterscheid, Zakk
    Schultz-Fademrecht, Carsten
    Esdar, Christina
    Schadt, Oliver
    Eickhoff, Jan
    Lowy, Andrew M.
    ONCOTARGET, 2016, 7 (29) : 45959 - 45975
  • [9] A Comprehensive Review of HER2 in Cancer Biology and Therapeutics
    Cheng, Xiaoqing
    GENES, 2024, 15 (07)
  • [10] Preclinical neuroprotective actions of xenon and possible implications for human therapeutics: a narrative review
    Maze, Mervyn
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2016, 63 (02): : 212 - 226